New hope for advanced colon cancer patients: triple therapy shows promise in liver metastasis
NCT ID NCT06071052
First seen Jan 06, 2026 · Last updated May 14, 2026 · Updated 16 times
Summary
This study tested a combination of three treatments for people with colorectal cancer that has spread to the liver and no longer responds to standard therapies. The approach combines two minimally invasive procedures (DEBIRI-TACE and HAIC) with a targeted drug called regorafenib. The goal was to see if this triple therapy could shrink tumors and extend survival in 21 participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER METASTASIS COLON CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
the first affiliated hospital, Sun-Yat sen university
Guangzhou, Guangdong, 510000, China
Conditions
Explore the condition pages connected to this study.